Amy Landucci is the Global Head, Digital Medicines at Novartis Pharmaceuticals. The first person to ever hold this role, Amy and her team are responsible for defining the company’s digital strategy and strengthening cross-divisional digital medicines activities that impact everything from clinical trials to patient engagement.
As part of her directive, Amy has spearheaded the creation of Novartis’ Digital Acceleration Laboratory, which leverages the latest digital technologies to accelerate the speed of R&D. She also drives strategic efforts to partner with external organizations that complement Novartis’ internal work.
She joined the Novartis Pharmaceutical Division in 2004, having previously worked at Accenture. Since then she held roles of increasing responsibility in Novartis’ US Commercial IT function, including being appointed CIO for the Over the Counter division in 2012, until she was appointed to her current position at the start of 2015.